Rx (Prescription Medicine)
USD $ 69.00
Decitex 50mg Injection 是一种重要的药物，用于治疗特定类型的癌症，尤其是骨髓增生异常综合征（MDS）和急性髓系白血病（AML）。其活性成分为去甲基化剂类药物的一种——去甲基胞苷（decitabine）。去甲基胞苷通过改变癌细胞的 DNA，帮助恢复正常基因功能，并抑制异常细胞的生长与增殖。通过干扰导致异常细胞不受控制分裂的过程，Decitex 旨在减缓或停止疾病的进展。该药物通常由医护专业人员以静脉注射或皮下注射的方式给予。常见的不良反应可能包括疲劳、发热、血细胞计数下降（导致感染、出血和贫血风险增加）、恶心、呕吐和腹泻。务必与医生讨论潜在的不良反应和注意事项。Decitex 50mg Injection 应按照生产厂家的说明进行保存，通常在受控的室温下保存并避光。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Decitabine 50 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
